Pentamidine Isethionate Injection — FDA Drug Shortage

To Be Discontinued — XGen Pharmaceuticals DJB, Inc.

The FDA lists a drug shortage record for Pentamidine Isethionate Injection (injection) from XGen Pharmaceuticals DJB, Inc. with status To Be Discontinued. The shortage was first posted on Mar 23, 2026.

Shortage details

Status
To Be Discontinued
Company
XGen Pharmaceuticals DJB, Inc.
Package NDC
39822-3050-2
Dosage Form
Injection
Presentation
Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)
Initial Posting
Mar 23, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.